Abstract
We have expressed α & β isoforms of mammalian striated muscle tropomyosin (Tm) and α-Tm carrying the D175N or E180G cardiomyopathy mutations. In each case the Tm carries an Ala-Ser N-terminal extension to mimic the acetylation of the native Tm. We show that these Ala-Ser modified proteins are good analogues of the native Tm in the assays used here. We go on to use an in vitro kinetic approach to define the assembly of actin filaments with the Tm isoforms with either a cardiac or a skeletal muscle troponin (cTn, skTn). With skTn the calcium sensitivity of the actin filament is the same for α & β-Tm and there is little change with the mutant Tms. For cTn switching from α to β-Tm causes an increase of calcium sensitivity of 0.2 pCa units. D175N is very similar to the wild type α-Tm and E180G shows a small increase in calcium sensitivity of about 0.1 pCa unit. The formation of the switched-off blocked-state of the actin filament is independent of the Tm isoform but does differ for cardiac versus skeletal Tn. The in vitro assays developed here provide a novel, simple and efficient method for assaying the behaviour of expressed thin filament proteins.
Similar content being viewed by others
Introduction
Striated muscle contraction is activated by calcium binding to the thin filament protein troponin (Tn; Ebashi et al. 1971; Gordon et al. 2000). The activation signal is coupled to the movement of tropomyosin (Tm) over the surface of the actin monomers of the thin filament (Craig and Lehman 2001; Pirani et al. 2006; Tao 1990). This movement relieves the inhibition of myosin binding and allows the ATP driven actomyosin contractile cycle to operate. The exact details of the activation process are still the subject of active research but most observers agree that a calcium induced change in the conformation of Tn (Takeda et al. 2003; Vinogradova et al. 2005) is coupled to changes in the interaction between Tm and actin, and this leads to activation of contraction. Here we are concerned with the role of the different isoforms of striated muscle Tm, α and β and how these interact with skeletal or cardiac Tn (skTn, cTn) to influence the calcium sensitivity of contraction.
Striated muscle Tm is α-helical rod-like protein that forms a parallel coiled-coil dimer which polymerises head-to-tail along the surface of actin. Mammalian striated muscle cells, both cardiac and skeletal, express Tm from two genes (TM1 & TM2) and at the protein level these are known as α-Tm & β-Tm (Lees-Miller and Helfman 1991; Helfman 1994). The α-Tm is more stable and the αα dimer predominates in most muscles. β-Tm is relatively unstable as a ββ dimer and is rarely found but the αβ heterodimer is stable and most mammalian striated muscle contains both αα & αβ-Tm (Lehrer and Joseph 1987; Lehrer et al. 1989; Lehrer and Qian 1990; Jagatheesan et al. 2003). The physiological role of αβ vs. αα-Tm is not understood but it is known that the proportion of αβ is increased in the slower contracting muscles of larger animals and can increase under certain diseased conditions (Heeley et al. 1983; Perry 2001). The α-Tm and β-Tm isoforms are identical in skeletal and cardiac muscle, the only difference is the proportion of αα vs. αβ can vary. Cardiac muscles of small mammals express virtually pure αα-Tm and transgenic mouse lines over-expressing β-Tm showed changes in calcium sensitivity and cardiac abnormalities that were lethal (Muthuchamy et al. 1995, 1998). To date there has been no detailed study of the calcium regulation of actin filaments containing β-Tm compared to α-Tm in vitro.
Alpha and beta Tm isoforms are found in all vertebrates. The sequence alignment of rat α & β-Tm is shown in Fig. 1. The sequence is 95% conserved with 87% identity. The 36 alterations in amino acid residues are distributed throughout the sequence but are more predominant in the C-terminal half. Individually both α-Tm and β-Tm sequences are highly conserved. Rat and rabbit β-Tm are identical and differ from human β-Tm at a single site, D66 in rat is E66 in human (swiss-prot P58775, P07951 & P58776 for rat human and rabbit β-Tm respectively). Rat α-Tm differs from rabbit at one site, K279 is N279 in rabbit, human has the same N279 as rabbit and K220 of rat and rabbit is replaced by R220 in human Tm (swiss-prot P04692, P09493, P58772).
We are interested in the functional significance of the Tm isoforms and have expressed the two rat Tm isoforms in E. coli with the Ala-Ser N-terminal extension which is used to mimic the native N-terminal acetylation (Monteiro et al. 1994). We show here that this appears to be a good model for the native Tm in the assays used. We have also made the non-conservative, K279N, mutation in α-Tm to make the rat sequence identical to the rabbit and only the one, K220R, conservative difference to the human sequence. Currently it is not possible to reliably assemble 100% αβ-Tm and therefore as a first step we examine the properties of the αα- & ββ-Tm isoforms and compare then to the well characterised native rabbit Tm which is an approximately 50:50 mixute of αα- and αβ-Tm in skeletal muscle.
In this study we assemble thin filaments with αα-Tm, ββ-Tm, then compare the calcium sensitivity of the thin filaments when assembled with rabbit skTn or human cTn and show that skeletal and cardiac Tns have a different sensitivity to the Tm isoforms. Two well-characterised point mutations of αα-Tm are also studied, E180G or D175N, using the same approach. (Thierfelder et al. 1994; Golitsina et al. 1997; Kremneva et al. 2004). These mutations are associated with Familial Hypertrophic Cardiomyopathies (FHC) but no phenotype has been reported with the expression of the mutation in skeletal muscle. We show that the αα-Tm carrying the mutations decrease the calcium required to activate the filament and the effect is smaller with skTn than cTn. However, the effects are small in each case (0.03–0.13 pCa unit).
The in vitro assays of calcium sensitivity used here are ones that we developed previously for defining the calcium sensitivity of skeletal and cardiac Tn (McKillop and Geeves 1993; Head et al. 1995; Reiffert et al. 1996). This measures the calcium sensitivity of the rate constant of myosin subfragment 1 (S1) binding to a large excess of thin filaments. An advantage of this assay is that it only measures the accessibility of the actin sites to the myosin heads. It does not measure the process of switching on of the filament; the assay is independent to a significant extent of the model used to explain activation of the filament. The method used here has not been adopted more widely for in vitro assays of calcium regulation. We demonstrate here that it can be used for a wide range of different thin filaments and will complement studies at the myofibril or muscle fibre level.
Materials and methods
Protein preparations
Rabbit actin was prepared as described by Spudich and Watt (1971) and its concentration was determined using the 280 nm extinction coefficient of 1.104 mg−1 ml cm−1 and a molecular mass of 42,000 Da. The procedure for the pyrene labelling of actin at Cys-374 was described by Criddle et al. (1985).
Rabbit myosin subfragment (S1) was prepared as described by Weeds and Taylor (1975). Its concentration was calculated using absorbance measurements at 280 nm with an extinction coefficient of 0.79 mg−1 ml cm−1 and a molecular mass of 115,000 Da.
Recombinant rat β-Tm with the Ala-Ser extension was amplified from a CGN vector (gift from Dr D.Helfman) using PCR primers which allowed the cloning of the entire coding sequence and the introduction of Nde I and Bam HI restriction sites. The gene was then introduced into pJC20 vector. The Ala-Ser extension shown to mimic acetylation (Monteiro et al. 1994) was introduced at the N-terminal end of the sequence using a 5′ primer with the additional Met-Ala.Ser amino acid sequences. The forward and reverse primer sequences were
5′-GGAATTCCATATGGCGAGCATGGACGCCATCAAGAAGAAGATGC-3′
5′-CGCGGATCCTCAGAGGGAAGTGATGTCATTGAGCG-3′
Recombinant rat α-Tm WT (with the point mutation K279N as in human α-Tm) and α-Tm containing FHC mutants D175N and E180G expressed with the Ala-Ser extension were cloned as described in Kremneva et al. (2004).
All recombinant Tm were over-expressed in BL-21 DE3(pLys) host cells and purified as described in Maytum et al. (2000) and Kremneva et al. (2004). Yields of pure protein were typically 20–40 mg from a 2 l culture. In each case the purified protein was characterized by mass spectrometry and the molecular mass agreed with that predicted from the sequence to within 3 Da. Protein concentrations were determined using absorbance at 280 nm with an extinction coefficient of 0.276 mg−1 ml cm−1 and monomer molecular mass of 32,800 Da.
Rabbit skTnTm complex from which skTn was isolated was obtained using the methods of Ebashi et al. (1971) and Greaser and Gergely (1971).
Human cardiac Tn was expressed, reconstituted and phosphorylated with the catalytic subunit of protein kinase A (PKA) as described by Deng et al. (2001). This resulted in the bisphosphorylation of the TnI subunit on Ser 22 and 23. The level of phosphorylation was checked by isoelectric focusing (Reiffert et al. 1999).
Thin filaments were assembled by incubating actin with the required concentrations of Tm and Tn (standard ratio A:Tm:Tn of 7:2:2) for 1 h before using in the measurements.
Co-sedimentation and densitometry
Co-sedimentation assays were performed at 20°C by mixing 10 μM polymerized F-actin with 0–3 μM Tm in 20 mM MOPS, 100 mM KCl, 2 mM MgCl2, pH 7.0 to reach a total volume of 100 μl. The samples were then incubated for at least 1 h. The polymerized actin and the Tm bound to it could then be pelleted by centrifugation at 100,000g for 20 min (Beckman TL100A). Equivalent samples of pellet and supernatant were then run on a 12% SDS-PAGE gels (Laemmli 1970), which were then stained with Coomassie Blue G-250. Densitometry analyses of the protein bands were carried out using an Epson 1640SU scanner and the Image-PC program (Scion Corp. based upon NIH-Image). The density of protein bands was measured by comparison to an integrated Kodak neutral density step tablet.
Calcium sensitivity measurements using stopped-flow technique
The calcium-dependent rate of S1 binding to pyrene-labelled actin was measured by monitoring the change in pyrene fluorescence in the stopped-flow machine (SF-61DX2 spectrophotometer, Hi-Tech Scientific). All the measurements were carried out at 20°C. Pyrene was excited at 365 nm and the emitted fluorescence was detected using a KV 389 nm cut off filter. The obtained data was visualised and analysed using the Kinetasyst software provided with the instrument. The protein concentrations cited in the text are those obtained after mixing. Each transient shown is the average of at least three shots. The k obs values, obtained from fitting the transients to a single exponential, were plotted as a function of pCa. The sigmoid curve was fitted to a version of the Hill equation
where K is the calcium concentration at the mid point of the titration, h is the Hill coefficient and the relative value of k obs is defined as the k′obs = (k obs−k 8.9)/(k 4.5−k 8.9) where the subscripts 8.9 and 4.5 refer to k obs values at the minimum and maximum of the the pCa range. The pCa values used were generated using mixture of 2 mM EGTA and 2 mM Ca-EGTA to produce the free calcium concentration required based on the affinity constants (Harrison and Bers 1987).
Results
The affinities of the expressed Tms for actin were measured in a sedimentation assay (see methods). Figure 2A shows the SDS-PAGE gels for the supernatant and pellets of a high-speed centrifugation of 10 μM actin with α-Tm in the range of 0.2–3 μM. The gel was subjected to a densitometer analysis and the band densities converted into concentrations of actin-bound and free Tm. The results are shown in Fig. 2B for both AS.α and AS.β-Tm. The data show that the amount of Tm that sedimented with actin increased up to a maximum, which was close to the expected 1 Tm per 7 actins. The binding curves were fitted to a Hill equation and both the affinity values (K 50%) and the Hill coefficient (h A ) are shown in Table 1. α- and βTm have similar affinities to actin of about 0.2 μM. In the absence of the AS N-terminal extension no significant binding of either Tm to actin was detected at up to 2 μM concentrations. This is consistent with previously published data using bacterially expressed α-Tm (Monteiro et al. 1994) and shows that the AS extension is essential for both α and β-Tm to bind to actin.
Table 1 also shows the affinities of actin for AS.α-Tm with FHC mutations D175N and E180G, which we previously reported (Kremneva et al. 2004). Both FHC mutations reduce the affinity of Tm binding to actin with a greater effect in the case of E180G mutation. The Hill coefficients suggests that the weaker the affinity the more cooperative the binding of Tm to actin. The precision of the assay for affinities below 0.5 μM is not high so this observed increase in Hill coefficient may be a limitation of the assay at these affinities tighter than 0.5 μM.
The rate at which S1 binds to actin is relatively independent of the presence of Tm and when calcium is present, addition of skTn has little effect on the observed rate constant of S1 binding (McKillop and Geeves 1993; Head et al. 1995; Schaertl et al. 1995). This is consistent with the actin.Tm and actin.TmTn (+calcium) filaments being largely in the same form as the pure actin filaments. In the absence of calcium, pre-incubation of actin with TmTn reduces the rate of S1 binding to actin; the form of the inhibition depends upon how the assay is performed. Figure 3A shows the pyrene actin fluorescence transient when 0.25 μM S1 is mixed with a ten-fold excess of pyr-actin in the absence or presence of a saturating level of native, rabbit-skeletal TmTn at low calcium concentrations (pCa 8.9). In the absence of TmTn the data is well described by a single exponential with k obs = 5.0 s−1. Addition of TmTn sufficient to saturate the actin filament gives a similar amplitude of the transient and can also be described by a single exponential with k obs = 1.1 s−1, an almost 5 fold reduction in k obs. The reduction in k obs by TmTn in the absence of calcium is consistent with previous measurements (McKillop and Geeves 1993; Head et al. 1995; Schaertl et al. 1995). The ratio of the k obs values for TmTn with and without calcium was on average 3.5:1 also consistent with the same literature.
Figure 3B shows the reduction in k obs as a function of TmTn concentration. A similar titration in the presence of calcium shows little effect of TmTn on k obs. In the absence of calcium the k obs is a linear function of TmTn concentration up to a break point and is then independent of TmTn concentration. The break point occurs at 0.6 μM TmTn. If the proteins were all 100% active and the TmTn binds with very high affinity to actin the break point would be expected to occur at 0.71 μM to give an actin7TmTn complex. The titration therefore provides a way of defining the quality of the proteins and the maximum extent of inhibition of the rate of S1 binding. The consistency of the result provides a simple test of the quality of assembly of the thin filament. Assembly of thin filaments with pyr-actin and tissue purified rabbit skeletal TmTn is very consistent in our hands as is the assembly using all of our recombinant Tms with skTn. Addition of skTmTn in the presence of calcium gives no more than 15% reduction in k obs and removing calcium reduces k obs further by a factor of 3.5 ± 0.5. Values outside this range are considered suspect and may indicate damaged troponin.
If S1 binding to actin at these low protein concentrations can be described as a simple single-step, bimolecular reaction then the k obs value is defined for a pure actin filament as k obs = [A]·k when actin is in excess of S1 and k is the apparent second order rate constant for S1 binding to actin. A reduction in k obs can be interpreted as a reduction in either the effective actin concentration or in k. In the presence of calcium the addition of TmTn leads to a small reduction in k obs and reflects either a small effect of TmTn upon k or an indication of the presence of some TmTn, which cannot be activated by calcium. The removal of calcium then leads to a further 3.5 fold reduction in k obs and has been interpreted as due to a fraction of the actin sites being unavailable. This idea was incorporated in to the 3-state thin filament model of (McKillop and Geeves 1993). In this model TmTn in the absence of calcium is in an equilibrium between 3-states: the M or open and C or closed states to which S1 can bind rapidly as for pure actin filaments and the B or blocked state to which S1 cannot effectively bind. For actin TmTn filaments in the absence of calcium then k obs = [A]·k K B /(1 + K B ) where K B is the equilibrium constant that defines the ratio of actin.TmTn complexes in the blocked and closed conformations (KB = [closed]/[blocked]) Thus K B /(1 + K B ) = 1/3.5, hence K B = 0.4. This assumes the occupancy of the open conformation is negligible.
It is important to emphasise the large reduction in k obs is the experimental observation and this is independent of the model used to interpret the data. There are other models of thin filament regulation(Tobacman and Butters 2000; Chen et al. 2001; Heeley et al. 2006) and currently there is no simple way to distinguish between these models. However, the data can be used to define aspects of the thin filament regulation that are independent of the detailed model used.
Assembly of thin filaments using cardiac Tn is more variable as reported previously (Lohmann et al. 2001) and the assay described in Fig. 3B provides a simple way to test that satisfactory thin filaments are being produced. For cTn and native Tm in the absence of calcium a four-fold reduction in k obs compared to unregulated actin is considered acceptable with saturation at between 1:7 and 2:7 ratio of Tn to actin. Preparations with properties outside this range were considered unacceptable and were rejected. The ratio of k obs in the presence and absence of calcium is normally lower than for skeletal Tn with 2.6 ± 0.3 being typical (Maytum et al. 2003).
Similar measurements were made with each of the recombinant Tms using an actin:Tm:Tn ratio of 7:2:2 with either skeletal or cardiac Tn. In all cases increasing the amount of Tm or Tn had no significant effect on the observed transients. A summary of the k obs values in the presence and absence of calcium and the derived K B values is shown in Table 2. These show that the ratio of the two rate constants (and hence K B ) is independent of the Tm isoform used. However, as noted previously, the ratio of the two rate constants is always smaller for cTn primarily because the value in the presence of calcium is smaller. Hence the value of K B is 0.33 ± 10% or 0.57 ± 10% for skTn and cTn respectively for each of the Tm isoforms investigated.
Having an experimental system that defines a well-regulated thin filament we can then use the method of Head et al. (1995) to define the calcium sensitivity of the novel thin filaments. The result of one such assay is shown in Fig. 4. Figure 4A shows the fluorescence transient observed for the binding of 0.25 μM S1 to a ten-fold excess of actin saturated with rabbit-skeletal TmTn. The measurement was repeated for a range of pCa values between 4.6 and 9.0. As can be seen the transients are all well defined by a single exponential and the k obs value decreases as the calcium concentration is decreased. A plot of the k obs against pCa is shown in Fig. 4B with the best fit to the Hill equation superimposed. This fit defined the mid-point of the calcium induced change in k obs as pCa 6.05 with a Hill coefficient (h Ca ) of 1.47.
A similar assay was performed for the α-Tm and the β-Tm with both skeletal and cardiac Tn. The pCa plots are shown in Fig. 4B and the best-fit parameters are listed in Table 1. In the presence of skTn the results for the two homodimers of Tm are indistinguishable with a mid-point of the pCa curve occurring at pCa 6.05 and a Hill coefficient of 1.5–1.68. In the presence of cTn the Hill coefficient for both Tms is 1.15–1.20, smaller than for skTn as expected as cTnC has single calcium binding site. The mid point pCa is lower for both Tms again as expected for cTn compared to skTn but now the two Tms differ pCa 5.80 for β-Tm and 5.57 for α-Tm. Comparing the data for the expressed homodimers with the native Tm shows no significant differences
The pCa measurement was repeated using the α-Tm carrying either of the two FHC mutations, D175N or E180G again using both sk and cTn. The pCa plots are shown in Fig. 4C together with a replot of the α-Tm from Fig. 4B for ease of comparison. The best-fit parameters to the Hill equation are given in Table 1. For cTn the Hill coefficients were unchanged for the 3 αTms while the midpoints increase for the two mutants by 0.09 pCa for D175N and 0.13 pCa for E180G. Using skTn, the mid point of the pCa curves showed smaller changes for the mutants than with cTn (0.03 for D175N, 0.10 for E180G) but a more pronounced decrease in the Hill coefficient was observed from 1.50 to 1.22 for D175N and to 1.19 for E180G. The significance of these results will be considered in the Discussion.
Discussion
In the work presented here we were interested in two major issues. Firstly, the extent to which the fast kinetic analysis that we have developed can be used to define the calcium sensitivity of a wide range of muscle thin filament proteins. Secondly, the role of the isoforms of Tm and Tn and the interaction between them in defining the calcium sensitivity of the thin filament.
The first requirement of any quantitative assay of a complex system like the muscle thin filament, which is assembled from five different protein chains, is to have a simple convenient assay that can establish that a correctly assembled filament has been achieved. This is not a trivial matter as less than 100% activity of any one of the components can severely limit the validity or at least the reproducibility of the assays. The relatively simple assay of Fig. 3 provides several criteria to establish a good thin filament preparation; the stoichiometry of the actin:Tm:Tn assembled, the degree to which Tn in the absence of calcium can turn the filament off (compared to a pure actin or actin.Tm filament) and the degree to which calcium can restore the full activity of the filament. In our hands actin and Tm always bind to each other at very close to the correct 7:1 ratio whether tissue purified or recombinant Tm is used. Tissue purified rabbit skeletal Tn is very reliable and assembles in a A7TmTn complex, which inhibits the rate of S1 binding by no more than 10–15% in the presence of calcium and by a further 3.5–4 fold when calcium is removed. Bovine cardiac Tn (tissue purified or recombinant, (Reiffert et al. 1996, 1999), or recombinant, human-cardiac Tn (Lohmann et al. 2001) behave differently. The cTn assembles more reliably when TnI is phosphorylated by PKA than when dephosphorylated. Only fully phosphorylated Tn was used in the experiments reported here. The filament assembles with an actin:Tn ratio of between 7:1 and 7:2 to give a maximally inhibited S1 binding and the maximal inhibition is similar to that observed with skTn. The difference is that addition of calcium does not restore the rate of S1 binding to the same extent as skTn, the rate in the presence of calcium being typically 25–30% lower than that for pure actin. This inhibition in the presence of calcium could be due to one of three things: 1, the presence of some damaged Tn component, which is inhibitory but does not activate on adding calcium. 2, That correctly assembled cTn does not activate fully on adding calcium (some blocked state always remains present); or 3, That cTn has an indirect effect on S1 binding by reducing k, the second order rate constant for S1 binding. At present the observed result appears consistent over a number of preparations over several years and we suspect therefore that it may be an intrinsic property of cTn implying that either some blocked state does remain in the presence of calcium or that k is altered. Equilibrium binding data using cardiac Tn in the presence of calcium does indicate that the filament is fully switched on and the data is indistinguishable from equivalent data for skTn (Maytum et al. 2000). There is unlikely therefore, to be any significant blocked state present in the presence of calcium and we assume this affect is due to an altered second order rate constant for S1 binding to actin.Tm.cTn.
The data of Table 1 establishes that recombinant Tm carrying the AS N-terminal extension is a good analogue of the native Tm, at least for the αα isoform. The affinity of AS.αα-Tm and AS.ββ-Tm for actin is tight (∼0.2 μM), quite similar and both bind with a 7:1 stoichiometry and assemble reliably with both skTn and cTn. The only marginal difference between the two was in the Hill coefficient (h A ) for binding of Tm to actin 2.7 for ββ compared to 1.95 for αα-Tm. Looking at the data in Fig. 2 this difference does not appear to be very well defined and is unlikely to be of physiological relevance. A comparison to the αβ-Tm heterodimer is required and we are currently refining the method for assembly of the heterodimer.
All actin.Tm filaments switch on more readily (a higher pCa for the mid-point and larger h Ca ) with skTn than with cTn. Calcium binding to TnC is different for cardiac versus skeletal Tn partly because of the different number of calcium binding sites in the regulatory domain of TnC. However the calcium affinity is also influenced by the interaction of TnC with the other Tn components and their interaction with Tm and actin (for review see Gordon et al. 2001). Our assays detect these small differences and this demonstrates the potential of this approach for exploring the information pathways through the actinTmTn complex. We have previously shown that the method can also detect the shift in the mid-point of the pCa curve caused by phosphorylation of TnI in cTn (Reiffert et al. 1996).
A comparison of thin filaments containing αα vs. ββ-Tm shows some interesting differences particularly in the presence of cTn. The ββ-Tm with cTn is more calcium sensitive by 0.23 pCa units (1.10 μM shift in calcium concentration) compared to αα-Tm with no measurable difference in the Hill coefficient. In contrast in the presence of skTn the calcium sensitivity was indistinguishable with a slightly larger value of the Hill coefficient for the β isoform but the difference is small (1.50 vs. 1.68). The data presented here are consistent with data obtained by over expression of β-Tm in mouse heart, which also showed an increase in calcium sensitivity (Palmiter et al. 1996).
A detailed interpretation of the sequence differences between α & β Tm is beyond the scope of the current work but the comparison shown in Fig. 1 reveals some features of interest. The coiled-coil structure of Tm is defined by the heptad repeat (abcdefg) of the amino acid sequence in which positions a & d are small hydrophobic residues and form the primary interaction between the two chains, positions e & g can provide secondary contacts that are usually ionic in character. Of the 12 non-conservative sequence changes, three are at positions to directly influence coiled-coil stability (one at position a of the heptad repeat and two at postioins g/e). There are a further two Ala-to-Ser substitutions and one Ser-to-Ala substitutions at d positions of the heptad which are of interest in relation to the suggestion that alanine clusters at the coiled-coil interface are involved in defining the flexibility of Tm (Brown et al. 2001). The remaining 9 non-conservative subsitutions are at are at the heptad positions b, c, & f, so they are unlikely to influence the coiled-coil stability directly but can alter the interaction of Tm with its binding partners. Tm-Tm interactions are thought to occur in the overlap between the 8–10 N & C-terminal amino acids (Greenfield et al. 2001). There are no sequence changes at the N-terminus but three conservative changes at the C-terminus. This overlap region is also thought to be a site of interaction of the N-terminal part of TnT. The major Tn interaction site is about one third of the length of Tm away from the C-terminus and close to the alternatively spliced exon 6 (see Fig. 1). In this region there are four non-conservative sequence changes (G188S, A191G, T199I, Q216T) and two conserved E to D changes. These are therefore in a position to alter the interaction of Tn with αα and ββ Tm as shown by the effects of exon 6 substitutions on calcium sensitivity (Maytum et al. 2004).
The AS.αα-Tm carrying one of the two FHC mutations have been studied by several groups (Golitsina et al. 1997; Bottinelli et al. 1998; Bing et al. 2000; Chang et al. 2005). We previously reported that there was a small difference in the affinities of the two proteins for actin compared to αα and that the E180G mutation was less thermally stable than WT protein both in the presence and absence of actin (Kremneva et al. 2004). Here we show that D175N Tm shows little change in calcium sensitivity compared to WT using either skTn (+0.03 pCa) or cTn (+0.09 pCa). E180G shows a slightly larger shift (+0.10 and +0.13 respectively). The data for D175N are within the error of the measurement while that for E180G is about twice the standard error. This is clearly seen in the data plotted in Fig. 4B as is the smaller cooperativity for E180G filaments with skTn but not cTn. These differences are at the limit of the sensitivity of the assay. A 0.1 pCa unit shift of calcium sensitivity could be sufficient to cause a problem in the heart (phosphorylation of TnI is used to generate only 0.2 –0.3 pCa unit shift). The precision of the measurements would need to be improved to be confident that such a change is attributable to the mutation. The possibility remains that for E180G at least, the loss of stability near body temperature could cause a change in calcium sensitivity at temperatures close to 37°C.
The conclusion from these studies is that the rapid kinetic assay can provide a convenient tool for estimating the calcium sensitivity of thin filaments assembled from different combinations of Tm and Tn isoforms. The assays provide a direct measure of the fraction of actin sites unavailable to bind S1 and the calcium sensitivity and cooperativity of the switch between off and on states. We have shown differences between αα, ββ-Tm and αα-Tm carrying point mutations linked to hypertrophic cardiomyopathy. The differences observed depend upon which Tn isoform is used, cardiac or skeletal. The differences observed illustrate the subtle interaction between the components of the thin filament and indicate why single point mutations in Tm, for example, can lead to life-threatening myopathies in the heart yet the same mutation produces no apparent phenotype in skeletal muscle. Future studies will need to address the differences between homodimers and heterodimers of Tm, which will include αβ-Tm and Tm in which only one monomer carries a mutation.
The small values of the Hill coefficients for the calcium switching of the thin filaments provided little evidence to support long-range cooperativity along the filaments. The Hill coefficient of ∼1.5 for skTn is consistent with 2 calcium ions being required to switch on each Tn with little Tn-Tn cooperativity. For the cardiac Tn the Hill coefficient is above 1, consistent with some Tn-Tn cooperativity, but not by a very large margin.
Abbreviations
- Tm:
-
Tropomyosin
- α-Tm:
-
Alpha tropomyosin
- β-Tm:
-
Beta tropomyosin
- A:
-
Actin
- S1:
-
Myosin subfragment 1
- skTn:
-
Skeletal muscle troponin
- cTn:
-
Cardiac muscle troponin
- PKA:
-
Protein kinase A
- FHC:
-
Familial Hypertrophic Cardiomyopathies
References
Bing W, Knott A et al (2000) Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol 32:1489–1498
Bottinelli R, Coviello DA et al (1998) A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res 82:106–115
Brown JH, Kim KH et al (2001) Deciphering the design of the tropomyosin molecule. Proc Natl Acad Sci USA 98:8496–8501
Chang AN, Harada K, Ackerman MJ, Potter JD (2005) Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosin. J Biol Chem 280:34343–34349
Chen Y, Yan B, Chalovich JM, Brenner B (2001) Theoretical kinetic studies of models for binding myosin subfragment-1 to regulated actin: Hill model versus Geeves model. Biophys J 80:2338–2349
Craig R, Lehman W (2001) Crossbridge and tropomyosin positions observed in native, interacting thick and thin filaments. J Mol Biol 311:1027–1036
Criddle AH, Geeves MA, Jeffries T (1985) The use of actin labelled with N-(1-pyrenyl)iodoacetamide to study the interaction of actin with myosin subfragments and troponin/tropomyosin. Biochem J 232:343–349
Deng Y, Schmidtmann A et al (2001) Effects of phosphorylation and mutation R145G on human cardiac troponin I function. Biochemistry 40:14593–14602
Ebashi S, Wakabayashi T, Ebashi F (1971) Troponin and its components. J Biochem (Tokyo) 69:441–445
Golitsina N, An Y et al (1997) Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function. Biochemistry 36:4637–4642
Gordon AM, Homsher E, Regnier M (2000) Regulation of contraction in striated muscle. Physiol Rev 80:853–924
Gordon AM, Regnier M, Homsher E (2001) Skeletal and cardiac muscle contractile activation: tropomyosin “rocks and rolls”. News Physiol Sci 16:49–55
Greaser ML, Gergely J (1971) Reconstitution of troponin activity from three protein components. J Biol Chem 246:4226–4233
Greenfield NJ, Huang YJ et al (2001) Solution NMR structure and folding dynamics of the N terminus of a rat non-muscle alpha-tropomyosin in an engineered chimeric protein. J Mol Biol 312:833–847
Harrison SM, Bers DM (1987) The effect of temperature and ionic strength on the apparent Ca-affinity of EGTA and the analogous Ca-chelators BAPTA and dibromo-BAPTA. Biochim Biophys Acta 925:133–143
Head JG, Ritchie MD, Geeves MA (1995) Characterization of the equilibrium between blocked and closed states of muscle thin filaments. Eur J Biochem 227:694–699
Heeley DH, Belknap B, and White HD (2006) Maximal activation of skeletal muscle thin filaments requires both rigor myosin S1 and calcium. J Biol Chem 281:668–676
Heeley DH, Dhoot GK et al (1983) The effect of cross-innervation on the tropomyosin composition of rabbit skeletal muscle. FEBS Lett 152:282–286
Helfman DM (1994) The generation of protein isoform diversity by alternative RNA splicing. Soc Gen Physiol Ser 49:105–115
Jagatheesan G, Rajan S et al (2003) Functional importance of the carboxyl-terminal region of striated muscle tropomyosin. J Biol Chem 278:23204–23211
Kremneva E, Boussouf S et al (2004) Effects of two familial hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin. Biophys J 87:3922–3933
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Lees-Miller JP, Helfman DM (1991) The molecular basis for tropomyosin isoform diversity. Bioessays 13:429–437
Lehrer SS, Joseph D (1987) Differences in local conformation around cysteine residues in alpha alpha, alpha beta, and beta beta rabbit skeletal tropomyosin. Arch Biochem Biophys 256:1–9
Lehrer SS, Qian Y (1990) Unfolding/refolding studies of smooth muscle tropomyosin. Evidence for a chain exchange mechanism in the preferential assembly of the native heterodimer. J Biol Chem 265:1134–1138
Lehrer SS, Qian YD, Hvidt S (1989) Assembly of the native heterodimer of Rana esculenta tropomyosin by chain exchange. Science 246:926–928
Lohmann K, Westerdorf B et al (2001) Overexpression of human cardiac troponin in Escherichia coli: its purification and characterization. Protein Expr Purif 21:49–59
Maytum R, Bathe F, Konrad M, Geeves MA (2004) Tropomyosin exon 6b is troponin-specific and required for correct acto-myosin regulation. J Biol Chem 279:18203–18209
Maytum R, Geeves MA, Konrad M (2000) Actomyosin regulatory properties of yeast tropomyosin are dependent upon N-terminal modification. Biochemistry 39:11913–11920
Maytum R, Westerdorf B, Jaquet K, Geeves MA (2003) Differential regulation of the actomyosin interaction by skeletal and cardiac troponin isoforms. J Biol Chem 278:6696–6701
McKillop DF, Geeves MA (1993) Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament. Biophys J 65:693–701
Monteiro PB, Lataro RC, Ferro JA, Reinach FdeC (1994) Functional alpha-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group. J Biol Chem 269:10461–10466
Muthuchamy M, Boivin GP, Grupp IL, Wieczorek DF (1998) Beta-tropomyosin overexpression induces severe cardiac abnormalities. J Mol Cell Cardiol 30:1545–1557
Muthuchamy M, Grupp IL et al (1995) Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J Biol Chem 270:30593–30603
Palmiter KA, Kitada Y et al (1996) Exchange of beta- for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding, and protein phosphorylation. J Biol Chem 271:11611–11614
Perry SV (2001) Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Motil 22:5–49
Pirani A, Vinogradova MV et al (2006) An atomic model of the thin filament in the relaxed and ca(2+)-activated States. J Mol Biol 357:707–717
Reiffert SU, Jaquet K et al (1996) Bisphosphorylation of cardiac troponin I modulates the Ca(2+)-dependent binding of myosin subfragment S1 to reconstituted thin filaments. FEBS Lett 384:43–47
Reiffert S, Maytum R et al (1999) Characterization of the cardiac holotroponin complex reconstituted from native cardiac troponin T and recombinant I and C. Eur J Biochem 261:40–47
Schaertl S, Lehrer SS, Geeves MA (1995) Separation and characterization of the two functional regions of troponin involved in muscle thin filament regulation. Biochemistry 34:15890–15894
Spudich JA, Watt S (1971) The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. J Biol Chem 246:4866–4871
Takeda S, Yamashita A, Maeda K, Maeda Y (2003) Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 424:35–41
Thierfelder L, Watkins H et al (1994) Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77:701–712
Tobacman LS, Butters CA (2000) A new model of cooperative myosin-thin filament binding. J Biol Chem 275:27587–27593
Vinogradova MV, Stone DB et al (2005) Ca(2+)-regulated structural changes in troponin. Proc Natl Acad Sci USA 102:5038–5043
Weeds AG, Taylor RS (1975) Separation of subfragment-1 isoenzymes from rabbit skeletal muscle myosin. Nature 257:54–56
Acknowledgements
This work was supported by a British Heart Foundation Studentship to SEB (FS/2000014) and by the NIH (AR048776) and the Wellcome Trust (Program Grant No 070021). We thank Darl Swartz and Sherwin Lehrer for helpful comments on the manuscript and N Adamek for technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Boussouf, S.E., Maytum, R., Jaquet, K. et al. Role of tropomyosin isoforms in the calcium sensitivity of striated muscle thin filaments. J Muscle Res Cell Motil 28, 49–58 (2007). https://doi.org/10.1007/s10974-007-9103-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10974-007-9103-z